How a dad turned his daughter's cerebral palsy into not one but two products for movement disorders. Now, the San Francisco ...

Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...

People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...

The MIND diet significantly reduces disability and fatigue, improving quality of life for people with MS, a long-term study ...

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

Major revisions to the diagnostic criteria for neuromyelitis optica spectrum disorder will broaden their scope to related syndromes and have a substantial clinical impact.

New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple SclerosisAcross non-active progressive MS (primary progressive and secondary ...

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

Sanofi's tolebrutinib review for non-relapsing multiple sclerosis has been extended by the FDA until December 2025.

For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...